Exane Derivatives’s Vertiv VRT Stock Holding History

Exane Derivatives’s Portfolio VRT Stock Details VRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-495	Closed	-$6.93K	–	994
2022 Q1	$6.93K	Buy	+495	New	+$8.8K	﹤0.01%	684

Other funds holding VRT

PEA

Platinum Equity Advisors Beverly Hills, California $8.96B AUM 31.4% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NSCM

New South Capital Management Memphis, Tennessee $2.28B AUM 47.19% 1-Year Est. Return

Exane Derivatives's VRT Position: Q2 2022 in Review

Exane Derivatives sold out of Vertiv (VRT) in Q2 2022, closing a stake of 495 shares — an estimated $6.93K sold.

Exane Derivatives first reported a position in VRT in Q1 2022 and held it in 1 quarter. The position peaked at $6.93K in Q1 2022. 289 funds tracked by Wall St. Rank hold VRT as of Q2 2022.

Exane Derivatives reported no remaining Vertiv position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 495 Vertiv shares in Q2 2022, an estimated $6.93K.
Exane Derivatives first reported a position in Vertiv in Q1 2022 and held it in 1 quarter.
Exane Derivatives's Vertiv position peaked at $6.93K in Q1 2022.
289 funds tracked by Wall St. Rank held Vertiv as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.